Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.
BMJ. 2020 Apr 29;369:m1107. doi: 10.1136/bmj.m1107.
BMJ. 2020.
PMID: 32349976
No abstract available.